| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.06e-07 | 37 | 82 | 5 | GO:0043425 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.44e-06 | 86 | 82 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MED15 KMT2C TSC22D1 MRTFB MED9 BRD4 SIAH2 RERE BCL9 KMT2E CREBBP EP300 | 3.03e-06 | 562 | 82 | 12 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.21e-06 | 303 | 82 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | p53 binding | 1.62e-05 | 77 | 82 | 5 | GO:0002039 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.67e-05 | 2 | 82 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.67e-05 | 2 | 82 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX9 POU6F2 CUX2 ZNF219 DMRT3 NFATC1 ASCL1 KLF5 FOSB MAZ NR4A3 MNT EP300 SMAD5 SP7 TBX5 | 3.92e-05 | 1244 | 82 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | chromatin binding | SOX9 TNRC18 EP400 NFATC1 ASCL1 BRD4 MAZ AUTS2 RERE CREBBP MNT EP300 | 4.65e-05 | 739 | 82 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.98e-05 | 3 | 82 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX9 POU6F2 CUX2 ZNF219 DMRT3 NFATC1 ASCL1 KLF5 FOSB MAZ NR4A3 MNT EP300 SMAD5 SP7 TBX5 | 5.08e-05 | 1271 | 82 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED15 MAGI2 KMT2C TSC22D1 MRTFB MED9 BRD4 DAB2 SIAH2 RERE BCL9 KMT2E CREBBP EP300 YTHDF2 | 6.69e-05 | 1160 | 82 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator binding | 7.15e-05 | 54 | 82 | 4 | GO:0001223 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX9 POU6F2 CUX2 ZNF219 DMRT3 NFATC1 ASCL1 KLF5 FOSB MAZ NR4A3 CREBBP MNT EP300 SMAD5 SP7 TBX5 | 7.48e-05 | 1459 | 82 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.84e-05 | 446 | 82 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED15 MAGI2 KMT2C TSC22D1 MRTFB MED9 BRD4 DAB2 SIAH2 RERE BCL9 KMT2E CREBBP BAG6 EP300 YTHDF2 | 1.09e-04 | 1356 | 82 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.22e-04 | 363 | 82 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX9 POU6F2 CUX2 ZNF219 DMRT3 NFATC1 ASCL1 KLF5 FOSB MAZ YLPM1 NR4A3 MNT SMAD5 SP7 TBX5 | 1.74e-04 | 1412 | 82 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.08e-04 | 71 | 82 | 4 | GO:0042054 | |
| GeneOntologyMolecularFunction | MRF binding | 2.47e-04 | 6 | 82 | 2 | GO:0043426 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 3.46e-04 | 320 | 82 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.61e-04 | 229 | 82 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 3.86e-04 | 326 | 82 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase binding | 3.97e-04 | 35 | 82 | 3 | GO:0051019 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.59e-04 | 8 | 82 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 5.89e-04 | 9 | 82 | 2 | GO:0017151 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.31e-04 | 582 | 82 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 7.34e-04 | 10 | 82 | 2 | GO:0008353 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 7.34e-04 | 10 | 82 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.83e-04 | 44 | 82 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | protein kinase activity | 7.83e-04 | 600 | 82 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 8.58e-04 | 103 | 82 | 4 | GO:0008276 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.47e-03 | 14 | 82 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 1.47e-03 | 14 | 82 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.51e-03 | 120 | 82 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.60e-03 | 206 | 82 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.69e-03 | 15 | 82 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.93e-03 | 16 | 82 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 2.32e-03 | 64 | 82 | 3 | GO:0036002 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.48e-03 | 709 | 82 | 9 | GO:0016773 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.65e-03 | 140 | 82 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein kinase binding | SOX9 LATS1 NFATC1 CDK12 MAPKAPK2 SGK1 ADAM9 PTPN23 NR4A3 EP300 | 3.00e-03 | 873 | 82 | 10 | GO:0019901 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.02e-03 | 20 | 82 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.02e-03 | 20 | 82 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.33e-03 | 21 | 82 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.69e-03 | 753 | 82 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 3.99e-03 | 23 | 82 | 2 | GO:0140994 | |
| GeneOntologyMolecularFunction | kinase activity | 4.06e-03 | 764 | 82 | 9 | GO:0016301 | |
| GeneOntologyMolecularFunction | kinase binding | SOX9 LATS1 NFATC1 CDK12 MAPKAPK2 SGK1 ADAM9 PTPN23 NR4A3 EP300 | 6.23e-03 | 969 | 82 | 10 | GO:0019900 |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 6.73e-03 | 30 | 82 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 6.73e-03 | 30 | 82 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 7.17e-03 | 31 | 82 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.38e-03 | 417 | 82 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 8.16e-03 | 560 | 82 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 8.58e-03 | 34 | 82 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 8.62e-03 | 566 | 82 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 9.26e-03 | 105 | 82 | 3 | GO:0008170 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED15 SOX9 KMT2C TSC22D1 ZNF219 MRTFB NFATC1 CDK12 ASCL1 KLF5 MED9 FOSB BRD4 MAZ DAB2 AUTS2 NR4A3 BCL9 CREBBP FUBP3 EP300 SMAD5 SP7 TBX5 | 2.63e-10 | 1390 | 80 | 24 | GO:0045944 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | SOX9 TSC22D1 LATS1 NFATC1 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 7.01e-08 | 336 | 80 | 11 | GO:0071560 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX9 CUX2 ZNF219 PCBP3 NFATC1 ASCL1 KLF5 FOSB MAZ YLPM1 CPEB3 DAB2 NR4A3 CREBBP PLK3 MNT EP300 SMAD5 | 8.44e-08 | 1053 | 80 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | SOX9 TSC22D1 LATS1 NFATC1 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 8.63e-08 | 343 | 80 | 11 | GO:0071559 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX9 CUX2 ZNF219 PCBP3 NFATC1 ASCL1 KLF5 FOSB MAZ YLPM1 CPEB3 DAB2 NR4A3 SIAH2 RERE CREBBP PLK3 MNT EP300 SMAD5 | 2.58e-07 | 1399 | 80 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX9 CUX2 ZNF219 PCBP3 NFATC1 ASCL1 KLF5 FOSB MAZ YLPM1 CPEB3 DAB2 NR4A3 SIAH2 RERE CREBBP PLK3 MNT EP300 SMAD5 | 3.03e-07 | 1413 | 80 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED15 SOX9 KMT2C PRMT8 KMT2B EP400 BICRA MED9 BRD4 BANP RERE KMT2E CREBBP INO80D BAG6 EP300 | 1.18e-06 | 999 | 80 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.22e-06 | 276 | 80 | 9 | GO:0007179 | |
| GeneOntologyBiologicalProcess | response to growth factor | SOX9 MAGI2 JCAD TSC22D1 LATS1 NFATC1 MAPKAPK2 ASCL1 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 1.30e-06 | 883 | 80 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 2.11e-06 | 54 | 80 | 5 | GO:0032968 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 4.21e-06 | 62 | 80 | 5 | GO:0032786 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | SOX9 MAGI2 JCAD TSC22D1 LATS1 NFATC1 MAPKAPK2 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 4.40e-06 | 850 | 80 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | chromatin organization | SOX9 KMT2C PRMT8 KMT2B EP400 BICRA BRD4 BANP RERE KMT2E CREBBP INO80D BAG6 EP300 | 8.03e-06 | 896 | 80 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | MAGI2 TSC22D1 LATS1 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 8.44e-06 | 445 | 80 | 10 | GO:0141091 |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.00e-05 | 35 | 80 | 4 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.00e-05 | 35 | 80 | 4 | GO:0030511 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | MAGI2 TSC22D1 LATS1 ADAM9 DAB2 BCL9 CREBBP EP300 SMAD5 RNF111 | 1.69e-05 | 482 | 80 | 10 | GO:0007178 |
| GeneOntologyBiologicalProcess | chromatin remodeling | SOX9 KMT2C PRMT8 KMT2B EP400 BICRA BRD4 RERE KMT2E CREBBP INO80D EP300 | 2.71e-05 | 741 | 80 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 3.03e-05 | 16 | 80 | 3 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 3.08e-05 | 93 | 80 | 5 | GO:0034243 | |
| GeneOntologyBiologicalProcess | regulation of stem cell differentiation | 4.16e-05 | 99 | 80 | 5 | GO:2000736 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 4.98e-05 | 338 | 80 | 8 | GO:0045165 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 5.51e-05 | 105 | 80 | 5 | GO:0032784 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.98e-05 | 347 | 80 | 8 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | SOX9 LATS1 EP400 CDK12 ASCL1 BRD4 CDK19 NR4A3 KMT2E CREBBP INO80D PLK3 MNT YTHDF2 CABLES1 | 8.48e-05 | 1256 | 80 | 15 | GO:0051726 |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.50e-05 | 115 | 80 | 5 | GO:0090100 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 8.87e-05 | 4 | 80 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.02e-04 | 192 | 80 | 6 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.11e-04 | 195 | 80 | 6 | GO:1903844 | |
| GeneOntologyBiologicalProcess | transcription elongation by RNA polymerase II | 1.36e-04 | 127 | 80 | 5 | GO:0006368 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell differentiation | 1.54e-04 | 27 | 80 | 3 | GO:2000738 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | SOX9 MAGI2 JCAD TSC22D1 LATS1 MAPKAPK2 ADAM9 DAB2 NR4A3 BCL9 CREBBP EP300 SMAD5 RNF111 | 1.71e-04 | 1186 | 80 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 1.72e-04 | 28 | 80 | 3 | GO:0018394 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | SOX9 LMOD3 CUX2 LATS1 NEDD4L TJP1 SGK1 KLF5 WASHC1 CPEB3 AUTS2 CGNL1 EP300 TBX5 | 1.75e-04 | 1189 | 80 | 14 | GO:0044087 |
| GeneOntologyBiologicalProcess | developmental growth | SOX9 MAGI2 KMT2C LATS1 NEDD4L KLF5 BRD4 AUTS2 PAK6 BCL9 EP300 TBX5 | 1.94e-04 | 911 | 80 | 12 | GO:0048589 |
| GeneOntologyBiologicalProcess | reflex | 2.34e-04 | 31 | 80 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription elongation | 2.44e-04 | 144 | 80 | 5 | GO:0006354 | |
| GeneOntologyBiologicalProcess | growth | SOX9 MAGI2 KMT2C LATS1 NEDD4L SGK1 KLF5 BRD4 DAB2 AUTS2 PAK6 BCL9 EP300 TBX5 | 2.59e-04 | 1235 | 80 | 14 | GO:0040007 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 2.60e-04 | 228 | 80 | 6 | GO:0045732 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 2.78e-04 | 81 | 80 | 4 | GO:0034605 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | SOX9 LATS1 NEDD4L MAPKAPK2 ADAM9 WASHC1 BANP CPEB3 DAB2 PABPC1 BAG6 PLK3 EP300 YTHDF2 | 2.98e-04 | 1252 | 80 | 14 | GO:0009894 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.43e-04 | 155 | 80 | 5 | GO:0043401 | |
| GeneOntologyBiologicalProcess | stem cell proliferation | 3.53e-04 | 156 | 80 | 5 | GO:0072089 | |
| GeneOntologyBiologicalProcess | embryo development | SOX9 SEC24D MRTFB LATS1 TJP1 BRD4 DAB2 NR4A3 CREBBP INO80D BAG6 EP300 YTHDF2 SMAD5 TBX5 | 3.69e-04 | 1437 | 80 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | SOX9 TSC22D1 TJP1 ASCL1 SGK1 MAZ DAB2 NR4A3 SIAH2 BAG6 PLK3 MNT SMAD5 | 3.94e-04 | 1133 | 80 | 13 | GO:0043066 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 3.97e-04 | 37 | 80 | 3 | GO:2000765 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 4.10e-04 | 8 | 80 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | SOX9 LMOD3 CUX2 ZNF219 ASCL1 SGK1 KLF5 BRD4 DAB2 EP300 SMAD5 SP7 TBX5 | 4.21e-04 | 1141 | 80 | 13 | GO:0045597 |
| GeneOntologyBiologicalProcess | limb bud formation | 5.25e-04 | 9 | 80 | 2 | GO:0060174 | |
| GeneOntologyBiologicalProcess | glial cell fate specification | 5.25e-04 | 9 | 80 | 2 | GO:0021780 | |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 5.25e-04 | 9 | 80 | 2 | GO:2000643 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | SOX9 TSC22D1 TJP1 ASCL1 SGK1 MAZ DAB2 NR4A3 SIAH2 BAG6 PLK3 MNT SMAD5 | 5.38e-04 | 1171 | 80 | 13 | GO:0043069 |
| GeneOntologyBiologicalProcess | neuron fate specification | 5.78e-04 | 42 | 80 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | learning or memory | 6.12e-04 | 373 | 80 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell proliferation | 6.20e-04 | 43 | 80 | 3 | GO:0071425 | |
| GeneOntologyBiologicalProcess | behavior | CUX2 DMRT3 AFF2 SGK1 FOSB CPEB3 AUTS2 NR4A3 PAK6 CREBBP EP300 | 6.31e-04 | 891 | 80 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | 6.49e-04 | 271 | 80 | 6 | GO:0000082 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | SOX9 LATS1 ASCL1 SGK1 FOSB ADAM9 DAB2 NR4A3 CREBBP EP300 SMAD5 SP7 | 6.86e-04 | 1048 | 80 | 12 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 6.93e-04 | 103 | 80 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 6.93e-04 | 381 | 80 | 7 | GO:0048545 | |
| GeneOntologyBiologicalProcess | memory | 7.31e-04 | 183 | 80 | 5 | GO:0007613 | |
| GeneOntologyBiologicalProcess | myotube differentiation involved in skeletal muscle regeneration | 7.99e-04 | 11 | 80 | 2 | GO:0014908 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 7.99e-04 | 11 | 80 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 8.21e-04 | 640 | 80 | 9 | GO:0006511 | |
| GeneOntologyBiologicalProcess | long-term memory | 8.57e-04 | 48 | 80 | 3 | GO:0007616 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 9.26e-04 | 651 | 80 | 9 | GO:0019941 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | MAGI2 LATS1 NEDD4L SGK1 ADAM9 WASHC1 AAK1 DAB2 PTPN23 CREBBP PLK3 EP300 | 9.44e-04 | 1087 | 80 | 12 | GO:0032880 |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron fate commitment | 9.56e-04 | 12 | 80 | 2 | GO:0060579 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in pattern specification | 9.56e-04 | 12 | 80 | 2 | GO:0060581 | |
| GeneOntologyBiologicalProcess | internal peptidyl-lysine acetylation | 9.56e-04 | 12 | 80 | 2 | GO:0018393 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 9.77e-04 | 656 | 80 | 9 | GO:0043632 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process | 1.02e-03 | 407 | 80 | 7 | GO:0042176 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | 1.04e-03 | 531 | 80 | 8 | GO:0042692 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.08e-03 | 299 | 80 | 6 | GO:0060560 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.09e-03 | 412 | 80 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | clathrin-dependent endocytosis | 1.14e-03 | 53 | 80 | 3 | GO:0072583 | |
| GeneOntologyBiologicalProcess | DNA damage response | EP400 MAPKAPK2 SGK1 BRD4 MARF1 CREBBP INO80D BAG6 PLK3 EP300 RNF111 | 1.15e-03 | 959 | 80 | 11 | GO:0006974 |
| GeneOntologyBiologicalProcess | protein catabolic process | SOX9 UBQLNL LATS1 NEDD4L ADAM9 BANP DAB2 PTPN23 SIAH2 BAG6 PLK3 RNF111 | 1.18e-03 | 1115 | 80 | 12 | GO:0030163 |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.19e-03 | 119 | 80 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 1.21e-03 | 54 | 80 | 3 | GO:0070849 | |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | 1.22e-03 | 306 | 80 | 6 | GO:0044843 | |
| GeneOntologyBiologicalProcess | response to heat | 1.26e-03 | 121 | 80 | 4 | GO:0009408 | |
| GeneOntologyBiologicalProcess | neuron projection development | MAGI2 CUX2 MRTFB NEDD4L SGK1 CPEB3 DAB2 AUTS2 NR4A3 RERE PAK6 CREBBP EP300 | 1.27e-03 | 1285 | 80 | 13 | GO:0031175 |
| GeneOntologyBiologicalProcess | cognition | 1.27e-03 | 423 | 80 | 7 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.31e-03 | 14 | 80 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 1.31e-03 | 14 | 80 | 2 | GO:0021514 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 1.31e-03 | 14 | 80 | 2 | GO:2000321 | |
| GeneOntologyBiologicalProcess | cell fate specification | 1.34e-03 | 123 | 80 | 4 | GO:0001708 | |
| GeneOntologyBiologicalProcess | neuron development | MAGI2 CUX2 MRTFB NEDD4L ASCL1 SGK1 CPEB3 DAB2 AUTS2 NR4A3 RERE PAK6 CREBBP EP300 | 1.38e-03 | 1463 | 80 | 14 | GO:0048666 |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.43e-03 | 558 | 80 | 8 | GO:0060537 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.49e-03 | 58 | 80 | 3 | GO:0003197 | |
| GeneOntologyBiologicalProcess | internal protein amino acid acetylation | 1.51e-03 | 15 | 80 | 2 | GO:0006475 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 1.55e-03 | 701 | 80 | 9 | GO:0009896 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 1.55e-03 | 438 | 80 | 7 | GO:1902903 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.72e-03 | 16 | 80 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.72e-03 | 16 | 80 | 2 | GO:1900153 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.72e-03 | 16 | 80 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.89e-03 | 63 | 80 | 3 | GO:0003179 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.92e-03 | 335 | 80 | 6 | GO:0016358 | |
| GeneOntologyCellularComponent | chromatin | SOX9 POU6F2 CUX2 DMRT3 EP400 NFATC1 ASCL1 BICRA KLF5 FOSB BRD4 NR4A3 KMT2E CREBBP INO80D PLK3 MNT EP300 SMAD5 SP7 TBX5 | 1.72e-07 | 1480 | 82 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | MED15 SOX9 NFATC1 ASCL1 KLF5 MED9 NR4A3 BCL9 CREBBP EP300 SMAD5 TBX5 | 3.47e-06 | 596 | 82 | 12 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED15 KMT2C KMT2B AFF2 EP400 CDK12 ASCL1 BICRA MED9 BRD4 CDK19 RERE BCL9 KMT2E PABPC1 CREBBP INO80D SMAD5 | 5.01e-06 | 1377 | 82 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 4.55e-05 | 18 | 82 | 3 | GO:0019908 | |
| GeneOntologyCellularComponent | nuclear body | AFF2 EP400 NFATC1 CDK12 SGK1 CELF3 BANP YLPM1 PTPN23 RERE KMT2E CREBBP RNF111 | 4.71e-05 | 903 | 82 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 5.38e-04 | 9 | 82 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 7.03e-04 | 272 | 82 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.39e-03 | 56 | 82 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 1.78e-03 | 61 | 82 | 3 | GO:0000307 | |
| HumanPheno | Abnormal midface morphology | SOX9 KMT2C SEC24D KMT2B BICRA CDK19 SLC35A2 AUTS2 RERE KMT2E CREBBP HCCS EP300 SP7 | 5.02e-06 | 704 | 28 | 14 | HP:0000309 |
| HumanPheno | Abnormal earlobe morphology | 6.45e-06 | 137 | 28 | 7 | HP:0000363 | |
| HumanPheno | Simple ear | 7.20e-06 | 24 | 28 | 4 | HP:0020206 | |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 7.50e-06 | 52 | 28 | 5 | HP:0009834 | |
| HumanPheno | Upper extremity joint dislocation | 1.03e-05 | 96 | 28 | 6 | HP:0030310 | |
| HumanPheno | Thick eyebrow | 1.40e-05 | 154 | 28 | 7 | HP:0000574 | |
| HumanPheno | Plantar crease between first and second toes | 2.91e-05 | 2 | 28 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.91e-05 | 2 | 28 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.91e-05 | 2 | 28 | 2 | HP:0001042 | |
| HumanPheno | Gastroesophageal reflux | KMT2C KMT2B NEDD4L ASCL1 BICRA BRD4 CDK19 SLC35A2 RERE CREBBP EP300 | 4.55e-05 | 517 | 28 | 11 | HP:0002020 |
| HumanPheno | Abnormal calvaria morphology | SOX9 LMOD3 KMT2C SEC24D KMT2B NEDD4L BICRA BRD4 CDK19 SLC35A2 AUTS2 RERE KMT2E CREBBP EP300 SP7 TBX5 | 5.06e-05 | 1254 | 28 | 17 | HP:0002683 |
| HumanPheno | Short thumb | 5.12e-05 | 127 | 28 | 6 | HP:0009778 | |
| HumanPheno | Abnormality of the palmar creases | 5.26e-05 | 260 | 28 | 8 | HP:0010490 | |
| HumanPheno | Abnormal palmar dermatoglyphics | 6.03e-05 | 265 | 28 | 8 | HP:0001018 | |
| HumanPheno | Abnormality of calvarial morphology | SOX9 KMT2C SEC24D KMT2B NEDD4L BICRA BRD4 CDK19 SLC35A2 AUTS2 RERE KMT2E CREBBP EP300 SP7 TBX5 | 6.37e-05 | 1134 | 28 | 16 | HP:0002648 |
| HumanPheno | Duplication of phalanx of toe | 6.48e-05 | 15 | 28 | 3 | HP:0010181 | |
| HumanPheno | Elbow dislocation | 7.89e-05 | 84 | 28 | 5 | HP:0003042 | |
| HumanPheno | Laryngeal cartilage malformation | 8.71e-05 | 3 | 28 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 8.71e-05 | 3 | 28 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 8.71e-05 | 3 | 28 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 8.71e-05 | 3 | 28 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 8.71e-05 | 3 | 28 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 8.71e-05 | 3 | 28 | 2 | HP:0005895 | |
| HumanPheno | Abnormality of thumb phalanx | 8.88e-05 | 205 | 28 | 7 | HP:0009602 | |
| HumanPheno | Motor stereotypy | 8.93e-05 | 280 | 28 | 8 | HP:0000733 | |
| HumanPheno | Abnormal cheek morphology | 9.39e-05 | 282 | 28 | 8 | HP:0004426 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 9.77e-05 | 368 | 28 | 9 | HP:0031432 | |
| HumanPheno | Broad thumb | 1.10e-04 | 90 | 28 | 5 | HP:0011304 | |
| HumanPheno | High palate | SOX9 LMOD3 SEC24D KMT2B BICRA BRD4 CDK19 SLC35A2 RERE CREBBP EP300 SP7 TBX5 | 1.11e-04 | 794 | 28 | 13 | HP:0000218 |
| HumanPheno | Triangular shaped phalanges of the hand | 1.17e-04 | 214 | 28 | 7 | HP:0009774 | |
| HumanPheno | Midface retrusion | 1.17e-04 | 291 | 28 | 8 | HP:0011800 | |
| HumanPheno | Hypospadias | 1.18e-04 | 377 | 28 | 9 | HP:0000047 | |
| HumanPheno | Perseverative thought | 1.18e-04 | 377 | 28 | 9 | HP:0030223 | |
| HumanPheno | Single transverse palmar crease | 1.20e-04 | 215 | 28 | 7 | HP:0000954 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 1.30e-04 | 150 | 28 | 6 | HP:0009601 | |
| HumanPheno | Abnormal palate morphology | SOX9 LMOD3 KMT2C SEC24D KMT2B NEDD4L BICRA BRD4 CDK19 SLC35A2 RERE CREBBP HCCS EP300 SP7 TBX5 | 1.35e-04 | 1202 | 28 | 16 | HP:0000174 |
| HumanPheno | Full cheeks | 1.35e-04 | 151 | 28 | 6 | HP:0000293 | |
| HumanPheno | Abnormal esophagus physiology | SOX9 LMOD3 KMT2C KMT2B NEDD4L KCNC3 ASCL1 BICRA BRD4 CDK19 SLC35A2 RERE CREBBP EP300 | 1.35e-04 | 933 | 28 | 14 | HP:0025270 |
| HumanPheno | Inverted nipples | 1.41e-04 | 50 | 28 | 4 | HP:0003186 | |
| HumanPheno | Disordered formal thought process | 1.41e-04 | 386 | 28 | 9 | HP:0025769 | |
| HumanPheno | Absent earlobe | 1.59e-04 | 20 | 28 | 3 | HP:0000387 | |
| HumanPheno | Abnormal curvature of the vertebral column | SOX9 LMOD3 KMT2C SEC24D NEDD4L BICRA BRD4 CDK19 SLC35A2 AUTS2 RERE KMT2E CREBBP EP300 SP7 TBX5 | 1.61e-04 | 1219 | 28 | 16 | HP:0010674 |
| HumanPheno | Trichiasis | 1.74e-04 | 4 | 28 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.74e-04 | 4 | 28 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.74e-04 | 4 | 28 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.74e-04 | 4 | 28 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0031207 | |
| HumanPheno | Displacement of the urethral meatus | 1.76e-04 | 397 | 28 | 9 | HP:0100627 | |
| HumanPheno | Abnormal male urethral meatus morphology | 1.83e-04 | 399 | 28 | 9 | HP:0032076 | |
| HumanPheno | Abnormal dermatoglyphics | 2.00e-04 | 314 | 28 | 8 | HP:0007477 | |
| HumanPheno | Abnormal thought pattern | 2.01e-04 | 404 | 28 | 9 | HP:5200269 | |
| HumanPheno | Narrow mouth | 2.04e-04 | 234 | 28 | 7 | HP:0000160 | |
| HumanPheno | Cutaneous syndactyly | 2.08e-04 | 103 | 28 | 5 | HP:0012725 | |
| HumanPheno | Micrognathia | SOX9 LMOD3 SEC24D NEDD4L BICRA BRD4 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 2.08e-04 | 843 | 28 | 13 | HP:0000347 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | SOX9 LMOD3 SEC24D NEDD4L BICRA BRD4 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 2.14e-04 | 845 | 28 | 13 | HP:0009118 |
| HumanPheno | Abnormal mandible morphology | SOX9 LMOD3 SEC24D KMT2B NEDD4L BICRA BRD4 SLC35A2 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 2.43e-04 | 1118 | 28 | 15 | HP:0000277 |
| HumanPheno | Scoliosis | SOX9 LMOD3 KMT2C SEC24D NEDD4L BICRA BRD4 CDK19 SLC35A2 AUTS2 RERE CREBBP EP300 SP7 TBX5 | 2.53e-04 | 1122 | 28 | 15 | HP:0002650 |
| HumanPheno | Clinodactyly of the 5th finger | 2.70e-04 | 420 | 28 | 9 | HP:0004209 | |
| HumanPheno | Clinodactyly of hands | 2.75e-04 | 421 | 28 | 9 | HP:0001157 | |
| HumanPheno | Deviation of the 5th finger | 2.75e-04 | 421 | 28 | 9 | HP:0009179 | |
| HumanPheno | Abnormality of the tubular bones | SOX9 LMOD3 SEC24D BICRA BRD4 SLC35A2 RERE CREBBP EP300 SP7 TBX5 | 2.87e-04 | 632 | 28 | 11 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | SOX9 LMOD3 SEC24D BICRA BRD4 SLC35A2 RERE CREBBP EP300 SP7 TBX5 | 2.87e-04 | 632 | 28 | 11 | HP:0100714 |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.88e-04 | 5 | 28 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.88e-04 | 5 | 28 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.88e-04 | 5 | 28 | 2 | HP:0030421 | |
| HumanPheno | Abnormality of mouth size | 2.95e-04 | 425 | 28 | 9 | HP:0011337 | |
| HumanPheno | Hypoplastic ilia | 3.48e-04 | 63 | 28 | 4 | HP:0000946 | |
| HumanPheno | Perimembranous ventricular septal defect | 3.55e-04 | 26 | 28 | 3 | HP:0011682 | |
| HumanPheno | Short 1st metacarpal | 3.98e-04 | 27 | 28 | 3 | HP:0010034 | |
| HumanPheno | Feeding difficulties | SOX9 LMOD3 KMT2B NEDD4L BICRA BRD4 CDK19 SLC35A2 AUTS2 PTPN23 RERE KMT2E CREBBP HCCS EP300 | 4.05e-04 | 1168 | 28 | 15 | HP:0011968 |
| HumanPheno | Anisometropia | 4.31e-04 | 6 | 28 | 2 | HP:0012803 | |
| HumanPheno | Large foramen magnum | 4.31e-04 | 6 | 28 | 2 | HP:0002700 | |
| HumanPheno | Abnormality of the jaws | SOX9 LMOD3 SEC24D KMT2B NEDD4L BICRA BRD4 SLC35A2 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 4.34e-04 | 1175 | 28 | 15 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | SOX9 LMOD3 SEC24D KMT2B NEDD4L BICRA BRD4 SLC35A2 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 4.38e-04 | 1176 | 28 | 15 | HP:0030791 |
| HumanPheno | Radial deviation of finger | 4.39e-04 | 448 | 28 | 9 | HP:0009466 | |
| HumanPheno | Deeply set eye | 4.49e-04 | 266 | 28 | 7 | HP:0000490 | |
| HumanPheno | Abnormal iliac wing morphology | 4.67e-04 | 68 | 28 | 4 | HP:0011867 | |
| HumanPheno | Finger clinodactyly | 4.69e-04 | 452 | 28 | 9 | HP:0040019 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | SOX9 LMOD3 SEC24D NEDD4L BICRA BRD4 AUTS2 RERE CREBBP HCCS EP300 SP7 TBX5 | 4.84e-04 | 915 | 28 | 13 | HP:0009116 |
| HumanPheno | Broad eyebrow | 4.94e-04 | 29 | 28 | 3 | HP:0011229 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | 5.01e-04 | 456 | 28 | 9 | HP:0009485 | |
| HumanPheno | Autistic behavior | KMT2C CUX2 KMT2B AFF2 BICRA BRD4 CDK19 AUTS2 RERE CREBBP EP300 | 5.34e-04 | 678 | 28 | 11 | HP:0000729 |
| HumanPheno | Recurrent hand flapping | 5.47e-04 | 30 | 28 | 3 | HP:0100023 | |
| HumanPheno | Abnormality of the urethra | 5.79e-04 | 465 | 28 | 9 | HP:0000795 | |
| HumanPheno | Abnormal lateral ventricle morphology | 5.93e-04 | 129 | 28 | 5 | HP:0030047 | |
| HumanPheno | Deviated nasal septum | 6.02e-04 | 7 | 28 | 2 | HP:0004411 | |
| HumanPheno | Hypoplastic iliac wing | 6.03e-04 | 31 | 28 | 3 | HP:0002866 | |
| HumanPheno | Delayed myelination | 6.13e-04 | 280 | 28 | 7 | HP:0012448 | |
| HumanPheno | Abnormality of the lower urinary tract | SOX9 LMOD3 KMT2C POU6F2 KMT2B KCNC3 BICRA BRD4 SLC35A2 RERE CREBBP HCCS EP300 | 6.15e-04 | 937 | 28 | 13 | HP:0010936 |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | 6.47e-04 | 472 | 28 | 9 | HP:0000235 | |
| HumanPheno | Abnormal esophagus morphology | SOX9 LMOD3 KMT2C KMT2B NEDD4L KCNC3 ASCL1 BICRA BRD4 CDK19 SLC35A2 RERE CREBBP EP300 | 6.60e-04 | 1078 | 28 | 14 | HP:0002031 |
| HumanPheno | Short proximal phalanx of finger | 6.63e-04 | 32 | 28 | 3 | HP:0010241 | |
| HumanPheno | Abnormal sternum morphology | 6.67e-04 | 474 | 28 | 9 | HP:0000766 | |
| HumanPheno | Abnormal facial shape | SOX9 LMOD3 KMT2C SEC24D KMT2B NEDD4L KCNC3 SLC35A2 AUTS2 RERE KMT2E CREBBP HCCS EP300 SP7 | 6.74e-04 | 1221 | 28 | 15 | HP:0001999 |
| HumanPheno | Frontal upsweep of hair | 7.27e-04 | 33 | 28 | 3 | HP:0002236 | |
| HumanPheno | Patent foramen ovale | 7.30e-04 | 135 | 28 | 5 | HP:0001655 | |
| HumanPheno | Abnormality of upper limb joint | SOX9 KMT2B NEDD4L BICRA BRD4 SLC35A2 AUTS2 RERE CREBBP EP300 TBX5 | 7.51e-04 | 705 | 28 | 11 | HP:0009810 |
| HumanPheno | Abnormal finger morphology | SOX9 LMOD3 KMT2C KMT2B AFF2 NEDD4L BICRA BRD4 SLC35A2 AUTS2 RERE KMT2E CREBBP EP300 SP7 TBX5 | 7.79e-04 | 1385 | 28 | 16 | HP:0001167 |
| HumanPheno | Abnormality of refraction | SOX9 KMT2C KMT2B NEDD4L BICRA BRD4 SLC35A2 RERE CREBBP HCCS EP300 | 7.89e-04 | 709 | 28 | 11 | HP:0000539 |
| MousePheno | abnormal embryo development | SOX9 KMT2B EP400 TJP1 BICRA KLF5 BRD4 WASHC1 CLPTM1 YLPM1 DAB2 PTPN23 NR4A3 ZFR CREBBP INO80D EP300 SMAD5 RNF111 TBX5 | 9.87e-06 | 1370 | 71 | 20 | MP:0001672 |
| MousePheno | perinatal lethality | SOX9 MAGI2 KMT2C MRTFB LATS1 KMT2B NEDD4L ASCL1 AUTS2 RERE KMT2E CREBBP BAG6 MNT EP300 SP7 TBX5 | 3.73e-05 | 1130 | 71 | 17 | MP:0002081 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | SOX9 SEC24D KMT2B EP400 TJP1 DAB2 PTPN23 RERE CREBBP EP300 SMAD5 RNF111 TBX5 | 4.39e-05 | 700 | 71 | 13 | MP:0011098 |
| MousePheno | perimembraneous ventricular septal defect | 1.02e-04 | 92 | 71 | 5 | MP:0010418 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 1.08e-04 | 93 | 71 | 5 | MP:0008823 | |
| MousePheno | abnormal embryonic tissue morphology | CUX2 MRTFB KMT2B EP400 NFATC1 TJP1 YLPM1 DAB2 AUTS2 NR4A3 ZFR RERE CREBBP EP300 SMAD5 RNF111 | 1.18e-04 | 1116 | 71 | 16 | MP:0002085 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | SOX9 MAGI2 KMT2C MRTFB KMT2B NEDD4L NFATC1 ASCL1 BICRA AUTS2 RERE KMT2E CREBBP BAG6 MNT EP300 SP7 | 1.58e-04 | 1269 | 71 | 17 | MP:0011111 |
| Domain | Nuc_rcpt_coact_CREBbp | 1.86e-05 | 2 | 81 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.86e-05 | 2 | 81 | 2 | PF08214 | |
| Domain | KIX | 1.86e-05 | 2 | 81 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.86e-05 | 2 | 81 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.86e-05 | 2 | 81 | 2 | IPR031162 | |
| Domain | DUF902 | 1.86e-05 | 2 | 81 | 2 | PF06001 | |
| Domain | - | 1.86e-05 | 2 | 81 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.86e-05 | 2 | 81 | 2 | IPR010303 | |
| Domain | - | 1.86e-05 | 2 | 81 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.86e-05 | 2 | 81 | 2 | PF09030 | |
| Domain | - | 1.86e-05 | 2 | 81 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.86e-05 | 2 | 81 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.86e-05 | 2 | 81 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.86e-05 | 2 | 81 | 2 | IPR013178 | |
| Domain | KAT11 | 1.86e-05 | 2 | 81 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.86e-05 | 2 | 81 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.86e-05 | 2 | 81 | 2 | IPR003101 | |
| Domain | KIX | 1.86e-05 | 2 | 81 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.86e-05 | 2 | 81 | 2 | PS51727 | |
| Domain | WH2 | 1.49e-04 | 24 | 81 | 3 | PS51082 | |
| Domain | Ser/Thr_kinase_AS | 1.57e-04 | 357 | 81 | 8 | IPR008271 | |
| Domain | S_TKc | 1.63e-04 | 359 | 81 | 8 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.73e-04 | 362 | 81 | 8 | PS00108 | |
| Domain | FYrich_C | 1.84e-04 | 5 | 81 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.84e-04 | 5 | 81 | 2 | IPR003888 | |
| Domain | FYRC | 1.84e-04 | 5 | 81 | 2 | SM00542 | |
| Domain | FYRN | 1.84e-04 | 5 | 81 | 2 | SM00541 | |
| Domain | FYRN | 1.84e-04 | 5 | 81 | 2 | PF05964 | |
| Domain | FYRC | 1.84e-04 | 5 | 81 | 2 | PF05965 | |
| Domain | FYRC | 1.84e-04 | 5 | 81 | 2 | PS51543 | |
| Domain | FYRN | 1.84e-04 | 5 | 81 | 2 | PS51542 | |
| Domain | Bromodomain_CS | 1.90e-04 | 26 | 81 | 3 | IPR018359 | |
| Domain | AT_hook | 2.13e-04 | 27 | 81 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.13e-04 | 27 | 81 | 3 | IPR017956 | |
| Domain | Pkinase | 2.45e-04 | 381 | 81 | 8 | PF00069 | |
| Domain | Nuc_rcpt_coact | 2.76e-04 | 6 | 81 | 2 | IPR009110 | |
| Domain | BROMODOMAIN_1 | 5.49e-04 | 37 | 81 | 3 | PS00633 | |
| Domain | Bromodomain | 5.94e-04 | 38 | 81 | 3 | PF00439 | |
| Domain | SET | 7.44e-04 | 41 | 81 | 3 | PF00856 | |
| Domain | BROMODOMAIN_2 | 7.44e-04 | 41 | 81 | 3 | PS50014 | |
| Domain | BROMO | 7.99e-04 | 42 | 81 | 3 | SM00297 | |
| Domain | Bromodomain | 7.99e-04 | 42 | 81 | 3 | IPR001487 | |
| Domain | - | 7.99e-04 | 42 | 81 | 3 | 1.20.920.10 | |
| Domain | PROTEIN_KINASE_ATP | 8.39e-04 | 459 | 81 | 8 | PS00107 | |
| Domain | BAH | 9.96e-04 | 11 | 81 | 2 | SM00439 | |
| Domain | BAH | 9.96e-04 | 11 | 81 | 2 | PF01426 | |
| Domain | BAH | 9.96e-04 | 11 | 81 | 2 | PS51038 | |
| Domain | BAH_dom | 9.96e-04 | 11 | 81 | 2 | IPR001025 | |
| Domain | SET | 1.04e-03 | 46 | 81 | 3 | SM00317 | |
| Domain | Prot_kinase_dom | 1.26e-03 | 489 | 81 | 8 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.33e-03 | 493 | 81 | 8 | PS50011 | |
| Domain | SET_dom | 1.33e-03 | 50 | 81 | 3 | IPR001214 | |
| Domain | SET | 1.33e-03 | 50 | 81 | 3 | PS50280 | |
| Domain | Post-SET_dom | 2.14e-03 | 16 | 81 | 2 | IPR003616 | |
| Domain | PostSET | 2.14e-03 | 16 | 81 | 2 | SM00508 | |
| Domain | AT_hook | 2.14e-03 | 16 | 81 | 2 | PF02178 | |
| Domain | POST_SET | 2.14e-03 | 16 | 81 | 2 | PS50868 | |
| Domain | Kinase-like_dom | 2.40e-03 | 542 | 81 | 8 | IPR011009 | |
| Domain | ZZ | 2.72e-03 | 18 | 81 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.72e-03 | 18 | 81 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.72e-03 | 18 | 81 | 2 | PS01357 | |
| Domain | Znf_ZZ | 3.03e-03 | 19 | 81 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.03e-03 | 19 | 81 | 2 | SM00291 | |
| Domain | WH2_dom | 3.70e-03 | 21 | 81 | 2 | IPR003124 | |
| Domain | EPHD | 4.06e-03 | 22 | 81 | 2 | PS51805 | |
| Domain | PHD | 4.24e-03 | 75 | 81 | 3 | PF00628 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 9.56e-07 | 84 | 56 | 6 | M1008 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 4.14e-06 | 61 | 56 | 5 | M152 | |
| Pathway | REACTOME_ADIPOGENESIS | 4.65e-06 | 110 | 56 | 6 | M48259 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | NFATC1 KCNC3 MAPKAPK2 ADAM9 BRD4 NR4A3 SIAH2 CGNL1 PABPC1 CREBBP | 6.50e-06 | 431 | 56 | 10 | M39729 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 SOX9 KMT2C KMT2B NEDD4L TJP1 CDK12 SGK1 BANP AUTS2 NR4A3 CREBBP PLK3 EP300 RNF111 SP7 TBX5 | 1.62e-05 | 1387 | 56 | 17 | M734 |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.66e-05 | 39 | 56 | 4 | M29793 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | SOX9 KMT2B NEDD4L CDK12 SGK1 BANP AUTS2 NR4A3 PLK3 EP300 RNF111 TBX5 | 3.81e-05 | 768 | 56 | 12 | MM14851 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.00e-05 | 237 | 56 | 7 | M27786 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 4.23e-05 | 98 | 56 | 5 | M48247 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.03e-04 | 118 | 56 | 5 | M27316 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 1.11e-04 | 120 | 56 | 5 | M48233 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.26e-04 | 65 | 56 | 4 | M39682 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.54e-04 | 5 | 56 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.54e-04 | 5 | 56 | 2 | M27228 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.79e-04 | 301 | 56 | 7 | MM15983 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.86e-04 | 134 | 56 | 5 | M3574 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M22062 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.71e-04 | 32 | 56 | 3 | M39521 | |
| Pathway | PID_REG_GR_PATHWAY | 3.10e-04 | 82 | 56 | 4 | M115 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.21e-04 | 7 | 56 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.27e-04 | 8 | 56 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.27e-04 | 8 | 56 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.27e-04 | 8 | 56 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47451 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SOX9 KMT2B NEDD4L CDK12 SGK1 BANP AUTS2 NR4A3 PLK3 EP300 RNF111 TBX5 | 5.60e-04 | 1022 | 56 | 12 | MM15436 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 5.66e-04 | 96 | 56 | 4 | M27792 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 6.60e-04 | 100 | 56 | 4 | MM15826 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.83e-04 | 10 | 56 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.33e-04 | 11 | 56 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.33e-04 | 11 | 56 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.33e-04 | 11 | 56 | 2 | M26924 | |
| Pathway | PID_HES_HEY_PATHWAY | 9.05e-04 | 48 | 56 | 3 | M288 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 9.43e-04 | 110 | 56 | 4 | MM15977 | |
| Pathway | PID_FOXO_PATHWAY | 9.61e-04 | 49 | 56 | 3 | M136 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.97e-04 | 12 | 56 | 2 | M27765 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.08e-03 | 51 | 56 | 3 | M665 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 1.16e-03 | 200 | 56 | 5 | M48048 | |
| Pathway | PID_NFAT_3PATHWAY | 1.21e-03 | 53 | 56 | 3 | M113 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.21e-03 | 53 | 56 | 3 | MM15880 | |
| Pathway | PID_TGFBR_PATHWAY | 1.28e-03 | 54 | 56 | 3 | M286 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.35e-03 | 55 | 56 | 3 | M39351 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.37e-03 | 14 | 56 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1439 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27 | 1.57e-03 | 15 | 56 | 2 | M47973 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M953 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.65e-03 | 59 | 56 | 3 | M39886 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.79e-03 | 16 | 56 | 2 | M27121 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.79e-03 | 16 | 56 | 2 | MM1483 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.79e-03 | 16 | 56 | 2 | M27940 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.03e-03 | 17 | 56 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.03e-03 | 17 | 56 | 2 | M48025 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 2.18e-03 | 65 | 56 | 3 | M39374 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 2.28e-03 | 18 | 56 | 2 | M5290 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.28e-03 | 18 | 56 | 2 | M26942 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.54e-03 | 19 | 56 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.54e-03 | 19 | 56 | 2 | M46442 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 2.69e-03 | 70 | 56 | 3 | M13266 | |
| Pathway | PID_AP1_PATHWAY | 2.69e-03 | 70 | 56 | 3 | M167 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 2.81e-03 | 20 | 56 | 2 | MM14813 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.81e-03 | 20 | 56 | 2 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 2.81e-03 | 20 | 56 | 2 | M591 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.95e-03 | 360 | 56 | 6 | M27267 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.03e-03 | 73 | 56 | 3 | M638 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.10e-03 | 21 | 56 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.10e-03 | 21 | 56 | 2 | M27485 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.40e-03 | 22 | 56 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.40e-03 | 22 | 56 | 2 | MM1443 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MED15 SOX9 KMT2C TSC22D1 KLF5 MED9 CDK19 SIAH2 PAK6 PABPC1 CREBBP EP300 TBX5 | 3.41e-03 | 1432 | 56 | 13 | M509 |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.47e-03 | 157 | 56 | 4 | MM15226 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 3.63e-03 | 159 | 56 | 4 | M39373 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 3.71e-03 | 160 | 56 | 4 | M27498 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.72e-03 | 23 | 56 | 2 | M2821 | |
| Pathway | PID_P73PATHWAY | 3.79e-03 | 79 | 56 | 3 | M19 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.80e-03 | 161 | 56 | 4 | M27871 | |
| Pathway | WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM | 3.93e-03 | 80 | 56 | 3 | M45523 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.04e-03 | 24 | 56 | 2 | M13404 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 4.21e-03 | 82 | 56 | 3 | M2 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.39e-03 | 25 | 56 | 2 | M27880 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 4.41e-03 | 272 | 56 | 5 | M29619 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 4.74e-03 | 26 | 56 | 2 | M2499 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.74e-03 | 26 | 56 | 2 | M32 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.74e-03 | 26 | 56 | 2 | MM14793 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 4.81e-03 | 86 | 56 | 3 | M2642 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 4.97e-03 | 87 | 56 | 3 | M39465 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 5.10e-03 | 27 | 56 | 2 | MM14779 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.48e-03 | 28 | 56 | 2 | M27254 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 5.63e-03 | 91 | 56 | 3 | M27101 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 5.63e-03 | 91 | 56 | 3 | M39700 | |
| Pubmed | MED15 LENG8 SOX9 PRR12 KMT2C KMT2B EP400 BICRA KLF5 MAZ BANP YLPM1 MARF1 AUTS2 ZFR RERE BCL9 PABPC1 MCRIP2 CREBBP FUBP3 INO80D MNT EP300 YTHDF2 SMAD5 SP7 | 2.30e-17 | 1429 | 84 | 27 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | JCAD TNRC18 CUX2 MRTFB LATS1 AFF2 NEDD4L EP400 BICRA KLF5 YLPM1 DAB2 ZFR BCL9 KMT2E PABPC1 | 6.70e-15 | 430 | 84 | 16 | 35044719 |
| Pubmed | LENG8 KMT2C TSC22D1 LATS1 NEDD4L BICRA DAB2 PTPN23 CGNL1 WASH2P PAK6 CREBBP EP300 RNF111 | 1.17e-11 | 486 | 84 | 14 | 20936779 | |
| Pubmed | MED15 LENG8 PRR12 KMT2C TNRC18 KMT2B EP400 BICRA KLF5 BRD4 ZFR BCL9 PABPC1 CREBBP FUBP3 INO80D BAG6 MNT EP300 | 1.35e-11 | 1103 | 84 | 19 | 34189442 | |
| Pubmed | MED15 LENG8 PRR12 TNRC18 EP400 KLF5 BRD4 YLPM1 RERE BCL9 CREBBP | 5.23e-11 | 268 | 84 | 11 | 33640491 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | MED15 PRR12 KMT2C TNRC18 KMT2B EP400 BICRA AUTS2 RERE BCL9 CREBBP EP300 | 5.45e-11 | 351 | 84 | 12 | 38297188 |
| Pubmed | MED15 KMT2C MRTFB LATS1 KMT2B EP400 TJP1 CDK12 BRD4 YLPM1 PTPN23 ZFR CREBBP EP300 | 5.84e-11 | 549 | 84 | 14 | 38280479 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | MED15 LENG8 PRR12 KMT2C CDK12 YLPM1 AUTS2 ZFR BCL9 CREBBP FUBP3 EP300 YTHDF2 | 7.89e-11 | 457 | 84 | 13 | 32344865 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RABL6 PRR12 KMT2C TNRC18 KMT2B EP400 NFATC1 CDK12 MAPKAPK2 BICRA BRD4 BANP SLC35A2 SIAH2 BCL9 PLK3 EP300 CABLES1 | 1.25e-10 | 1105 | 84 | 18 | 35748872 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | MED15 PRR12 JCAD KMT2C TNRC18 EP400 BICRA BRD4 MAZ AUTS2 CREBBP EP300 | 2.30e-10 | 398 | 84 | 12 | 35016035 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX9 TSC22D1 POU6F2 CUX2 DMRT3 NFATC1 ASCL1 KLF5 FOSB MAZ NR4A3 RERE MNT SMAD5 SP7 TBX5 | 4.98e-10 | 908 | 84 | 16 | 19274049 |
| Pubmed | SEC24D MRTFB KMT2B NEDD4L CDK12 BRD4 YLPM1 DAB2 SIAH2 CREBBP BAG6 SMAD5 RNF111 | 1.80e-09 | 591 | 84 | 13 | 15231748 | |
| Pubmed | 3.64e-09 | 152 | 84 | 8 | 38360978 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | MED15 EP400 CDK12 MAPKAPK2 MED9 MAZ CDK19 PABPC1 CREBBP BAG6 EP300 YTHDF2 CABLES1 | 1.24e-08 | 695 | 84 | 13 | 23602568 |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 9590171 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 15380363 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 28398509 | ||
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 9194565 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | LENG8 PCBP3 EP400 TJP1 CDK12 BICRA BRD4 MAZ YLPM1 MARF1 ZFR PABPC1 FUBP3 YTHDF2 | 6.64e-08 | 954 | 84 | 14 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PRR12 KMT2C ZNF219 KMT2B EP400 KLF5 MED9 BRD4 MAZ BANP YLPM1 ZFR FUBP3 INO80D MNT EP300 | 7.25e-08 | 1294 | 84 | 16 | 30804502 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KMT2C TSC22D1 POU6F2 TNRC18 MRTFB NEDD4L NFATC1 TJP1 MAPKAPK2 BICRA CDK19 BANP AAK1 AUTS2 RERE CREBBP EP300 | 8.38e-08 | 1489 | 84 | 17 | 28611215 |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 15623506 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 12732631 | ||
| Pubmed | SOX9 KMT2C CUX2 ZNF219 KLF5 BRD4 NR4A3 ZFR CREBBP MNT RNF111 SP7 | 1.39e-07 | 709 | 84 | 12 | 22988430 | |
| Pubmed | MED15 LENG8 PRMT8 PCBP3 KMT2B CELF3 DAB2 SIAH2 RERE FUBP3 BAG6 | 2.50e-07 | 608 | 84 | 11 | 16713569 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 12788643 | ||
| Pubmed | 2.71e-07 | 23 | 84 | 4 | 9225980 | ||
| Pubmed | 2.76e-07 | 57 | 84 | 5 | 18022353 | ||
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 16332960 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 7.54e-07 | 8 | 84 | 3 | 23130995 | |
| Pubmed | 9.15e-07 | 425 | 84 | 9 | 24999758 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | TSC22D1 TJP1 CDK12 ADAM9 BRD4 MAZ CLPTM1 AUTS2 NR4A3 RERE KMT2E BAG6 MNT RNF111 | 1.08e-06 | 1203 | 84 | 14 | 29180619 |
| Pubmed | 1.28e-06 | 225 | 84 | 7 | 12168954 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | PCBP3 TJP1 MAZ YLPM1 AAK1 MARF1 ZFR PABPC1 MCRIP2 FUBP3 YTHDF2 | 1.38e-06 | 724 | 84 | 11 | 36232890 |
| Pubmed | 1.39e-06 | 34 | 84 | 4 | 32142630 | ||
| Pubmed | SOX9 LATS1 KMT2B CDK12 SGK1 ADAM9 BRD4 KMT2E CREBBP PLK3 EP300 | 1.49e-06 | 730 | 84 | 11 | 34857952 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.53e-06 | 146 | 84 | 6 | 23892456 | |
| Pubmed | Core Binding Factor β Plays a Critical Role During Chondrocyte Differentiation. | 1.61e-06 | 10 | 84 | 3 | 26058470 | |
| Pubmed | 1.61e-06 | 10 | 84 | 3 | 22300732 | ||
| Pubmed | 1.82e-06 | 83 | 84 | 5 | 28794006 | ||
| Pubmed | 2.21e-06 | 11 | 84 | 3 | 19501582 | ||
| Pubmed | 2.34e-06 | 157 | 84 | 6 | 30186101 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | LENG8 MRTFB EP400 TJP1 CDK12 YLPM1 AAK1 PTPN23 ZFR CGNL1 PABPC1 YTHDF2 | 2.51e-06 | 934 | 84 | 12 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.62e-06 | 774 | 84 | 11 | 15302935 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 2.80e-06 | 162 | 84 | 6 | 31363146 | |
| Pubmed | 2.94e-06 | 12 | 84 | 3 | 37298583 | ||
| Pubmed | Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. | 2.94e-06 | 12 | 84 | 3 | 15923624 | |
| Pubmed | Tbx20 interacts with smads to confine tbx2 expression to the atrioventricular canal. | 2.94e-06 | 12 | 84 | 3 | 19661464 | |
| Pubmed | 3.81e-06 | 506 | 84 | 9 | 30890647 | ||
| Pubmed | 3.82e-06 | 13 | 84 | 3 | 26739452 | ||
| Pubmed | 4.49e-06 | 272 | 84 | 7 | 31010829 | ||
| Pubmed | Wnt/β-catenin signaling regulates sequential fate decisions of murine cortical precursor cells. | 4.78e-06 | 46 | 84 | 4 | 25182747 | |
| Pubmed | 4.85e-06 | 14 | 84 | 3 | 30413887 | ||
| Pubmed | NFATc1 balances quiescence and proliferation of skin stem cells. | 4.85e-06 | 14 | 84 | 3 | 18243104 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.14e-06 | 180 | 84 | 6 | 35198878 | |
| Pubmed | 5.68e-06 | 48 | 84 | 4 | 27703004 | ||
| Pubmed | 5.70e-06 | 399 | 84 | 8 | 35987950 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 5.76e-06 | 2 | 84 | 2 | 34845315 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19729597 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 26253517 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20466724 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 39287984 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15576372 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20717166 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 25893291 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11559821 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 32576962 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19822209 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 5.76e-06 | 2 | 84 | 2 | 21847097 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 5.76e-06 | 2 | 84 | 2 | 34813504 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20301699 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15117818 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15958725 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24639469 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 5.76e-06 | 2 | 84 | 2 | 11438528 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 10918613 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 35502657 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 5.76e-06 | 2 | 84 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 5.76e-06 | 2 | 84 | 2 | 27881443 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 5.76e-06 | 2 | 84 | 2 | 32690000 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30953353 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21803292 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9811832 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24089570 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 5.76e-06 | 2 | 84 | 2 | 39266679 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22303793 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 5.76e-06 | 2 | 84 | 2 | 34019788 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 34167360 | ||
| Pubmed | BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization. | 5.76e-06 | 2 | 84 | 2 | 24852146 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 15860545 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 5.76e-06 | 2 | 84 | 2 | 24551300 | |
| Pubmed | Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves. | 5.76e-06 | 2 | 84 | 2 | 19019468 | |
| Interaction | ALG13 interactions | LENG8 PRR12 LATS1 MARF1 ZFR RERE BCL9 PABPC1 MCRIP2 FUBP3 EP300 YTHDF2 | 1.21e-11 | 183 | 83 | 12 | int:ALG13 |
| Interaction | SP7 interactions | LENG8 PRR12 KMT2C KMT2B EP400 BICRA YLPM1 ZFR RERE BCL9 CREBBP FUBP3 EP300 SP7 | 2.44e-11 | 304 | 83 | 14 | int:SP7 |
| Interaction | KLF5 interactions | LENG8 PRR12 KMT2C NEDD4L EP400 KLF5 BRD4 MAZ BCL9 CREBBP FUBP3 EP300 | 2.55e-11 | 195 | 83 | 12 | int:KLF5 |
| Interaction | TLE3 interactions | MED15 SOX9 PRR12 TNRC18 CDK12 KLF5 BRD4 AUTS2 RERE BCL9 CREBBP INO80D EP300 SP7 | 4.01e-10 | 376 | 83 | 14 | int:TLE3 |
| Interaction | NUP35 interactions | MED15 LENG8 PRR12 KMT2C CDK12 YLPM1 AUTS2 ZFR BCL9 CREBBP FUBP3 EP300 YTHDF2 TBX5 | 1.90e-09 | 424 | 83 | 14 | int:NUP35 |
| Interaction | EGR2 interactions | PRR12 KMT2C TNRC18 EP400 NFATC1 BICRA RERE BCL9 CREBBP EP300 | 2.12e-09 | 171 | 83 | 10 | int:EGR2 |
| Interaction | AR interactions | MED15 LENG8 PRR12 KMT2C TNRC18 EP400 TJP1 KLF5 BRD4 YLPM1 SIAH2 ZFR RERE PAK6 BCL9 PABPC1 CREBBP FUBP3 BAG6 EP300 | 2.46e-09 | 992 | 83 | 20 | int:AR |
| Interaction | GSC interactions | 2.63e-09 | 87 | 83 | 8 | int:GSC | |
| Interaction | ATN1 interactions | 5.03e-09 | 187 | 83 | 10 | int:ATN1 | |
| Interaction | HNF1B interactions | 5.86e-09 | 190 | 83 | 10 | int:HNF1B | |
| Interaction | EP300 interactions | RABL6 SOX9 NFATC1 CDK12 ASCL1 KLF5 FOSB BRD4 MAZ BANP YLPM1 AUTS2 NR4A3 SIAH2 ZFR RERE PABPC1 CREBBP FUBP3 BAG6 EP300 SMAD5 SP7 | 6.24e-09 | 1401 | 83 | 23 | int:EP300 |
| Interaction | SOX9 interactions | 6.30e-09 | 97 | 83 | 8 | int:SOX9 | |
| Interaction | CRX interactions | MED15 PRR12 KMT2C TNRC18 EP400 BICRA BANP RERE BCL9 CREBBP EP300 | 7.45e-09 | 254 | 83 | 11 | int:CRX |
| Interaction | TOP3B interactions | RABL6 PRR12 KMT2C TNRC18 KMT2B EP400 NFATC1 CDK12 MAPKAPK2 BICRA BRD4 BANP SLC35A2 SIAH2 ZFR BCL9 PABPC1 MCRIP2 FUBP3 PLK3 EP300 YTHDF2 CABLES1 | 1.54e-08 | 1470 | 83 | 23 | int:TOP3B |
| Interaction | KDM6A interactions | 2.22e-08 | 162 | 83 | 9 | int:KDM6A | |
| Interaction | PAX6 interactions | SOX9 PRR12 KMT2C EP400 KCNC3 BICRA BANP BCL9 CREBBP EP300 SMAD5 RNF111 | 3.27e-08 | 366 | 83 | 12 | int:PAX6 |
| Interaction | SMAD3 interactions | MED15 SOX9 MAGI2 KMT2B NEDD4L KLF5 DAB2 PABPC1 CREBBP EP300 YTHDF2 SMAD5 RNF111 | 3.41e-08 | 447 | 83 | 13 | int:SMAD3 |
| Interaction | EYA4 interactions | 6.08e-08 | 243 | 83 | 10 | int:EYA4 | |
| Interaction | NCOA6 interactions | 1.48e-07 | 145 | 83 | 8 | int:NCOA6 | |
| Interaction | FEV interactions | 1.54e-07 | 203 | 83 | 9 | int:FEV | |
| Interaction | KLF15 interactions | 3.14e-07 | 290 | 83 | 10 | int:KLF15 | |
| Interaction | ERG interactions | 3.42e-07 | 223 | 83 | 9 | int:ERG | |
| Interaction | YAP1 interactions | MED15 JCAD KMT2C TNRC18 MRTFB LATS1 KMT2B NEDD4L TJP1 CDK12 KLF5 BRD4 YLPM1 ZFR PABPC1 CREBBP EP300 SMAD5 | 3.84e-07 | 1095 | 83 | 18 | int:YAP1 |
| Interaction | TBR1 interactions | 4.22e-07 | 113 | 83 | 7 | int:TBR1 | |
| Interaction | SMARCC1 interactions | RABL6 SOX9 LATS1 NFATC1 BICRA BRD4 YLPM1 CREBBP FUBP3 EP300 SP7 | 4.93e-07 | 384 | 83 | 11 | int:SMARCC1 |
| Interaction | SMAD2 interactions | MED15 SOX9 KMT2C NEDD4L KLF5 MED9 DAB2 CREBBP EP300 SMAD5 RNF111 | 5.05e-07 | 385 | 83 | 11 | int:SMAD2 |
| Interaction | CEBPA interactions | MED15 LENG8 PRR12 KMT2C TNRC18 KMT2B EP400 BICRA KLF5 BRD4 ZFR BCL9 PABPC1 CREBBP FUBP3 INO80D BAG6 MNT EP300 | 5.34e-07 | 1245 | 83 | 19 | int:CEBPA |
| Interaction | CTBP1 interactions | MED15 PRR12 ZNF219 EP400 NFATC1 BRD4 MARF1 CREBBP BAG6 EP300 RNF111 | 8.52e-07 | 406 | 83 | 11 | int:CTBP1 |
| Interaction | CREBBP interactions | SOX9 LATS1 NFATC1 KLF5 FOSB BRD4 MARF1 NR4A3 CREBBP EP300 YTHDF2 RNF111 SP7 | 9.74e-07 | 599 | 83 | 13 | int:CREBBP |
| Interaction | NFIA interactions | 1.07e-06 | 188 | 83 | 8 | int:NFIA | |
| Interaction | SOX7 interactions | 1.11e-06 | 82 | 83 | 6 | int:SOX7 | |
| Interaction | KMT2C interactions | 1.34e-06 | 134 | 83 | 7 | int:KMT2C | |
| Interaction | CSNK2B interactions | LENG8 KMT2B EP400 TJP1 MAPKAPK2 BRD4 BANP AUTS2 CREBBP BAG6 EP300 RNF111 SP7 | 1.56e-06 | 625 | 83 | 13 | int:CSNK2B |
| Interaction | SMARCC2 interactions | 1.87e-06 | 353 | 83 | 10 | int:SMARCC2 | |
| Interaction | SMARCB1 interactions | 2.46e-06 | 364 | 83 | 10 | int:SMARCB1 | |
| Interaction | SMARCA4 interactions | RABL6 SOX9 EP400 NFATC1 BICRA BRD4 CDK19 CREBBP EP300 SP7 TBX5 | 2.98e-06 | 462 | 83 | 11 | int:SMARCA4 |
| Interaction | CTNNB1 interactions | MAGI2 JCAD TSC22D1 NEDD4L EP400 TJP1 SGK1 KLF5 MED9 BRD4 CGNL1 BCL9 PABPC1 CREBBP EP300 YTHDF2 | 3.03e-06 | 1009 | 83 | 16 | int:CTNNB1 |
| Interaction | HCFC1 interactions | 3.29e-06 | 293 | 83 | 9 | int:HCFC1 | |
| Interaction | FUBP3 interactions | 3.68e-06 | 297 | 83 | 9 | int:FUBP3 | |
| Interaction | CPEB4 interactions | 3.69e-06 | 156 | 83 | 7 | int:CPEB4 | |
| Interaction | PIN1 interactions | 3.87e-06 | 383 | 83 | 10 | int:PIN1 | |
| Interaction | NCOA3 interactions | 3.96e-06 | 224 | 83 | 8 | int:NCOA3 | |
| Interaction | MED29 interactions | 3.99e-06 | 102 | 83 | 6 | int:MED29 | |
| Interaction | YLPM1 interactions | 4.36e-06 | 160 | 83 | 7 | int:YLPM1 | |
| Interaction | NFIX interactions | 4.37e-06 | 227 | 83 | 8 | int:NFIX | |
| Interaction | FHL2 interactions | POU6F2 TNRC18 MRTFB EP400 WASHC1 BANP ZFR CREBBP EP300 RNF111 | 5.20e-06 | 396 | 83 | 10 | int:FHL2 |
| Interaction | PML interactions | MED15 PRMT8 KMT2B EP400 NFATC1 TJP1 BRD4 BANP AAK1 SIAH2 MCRIP2 CREBBP EP300 YTHDF2 RNF111 | 5.47e-06 | 933 | 83 | 15 | int:PML |
| Interaction | FOS interactions | 5.48e-06 | 312 | 83 | 9 | int:FOS | |
| Interaction | HOXA10 interactions | 5.65e-06 | 62 | 83 | 5 | int:HOXA10 | |
| Interaction | KMT2D interactions | 6.26e-06 | 169 | 83 | 7 | int:KMT2D | |
| Interaction | SMG7 interactions | 6.56e-06 | 319 | 83 | 9 | int:SMG7 | |
| Interaction | KLF8 interactions | 8.40e-06 | 329 | 83 | 9 | int:KLF8 | |
| Interaction | GCM1 interactions | 8.92e-06 | 68 | 83 | 5 | int:GCM1 | |
| Interaction | WWTR1 interactions | 9.07e-06 | 422 | 83 | 10 | int:WWTR1 | |
| Interaction | MAX interactions | 9.13e-06 | 251 | 83 | 8 | int:MAX | |
| Interaction | MED20 interactions | 9.81e-06 | 181 | 83 | 7 | int:MED20 | |
| Interaction | CREB1 interactions | 9.95e-06 | 254 | 83 | 8 | int:CREB1 | |
| Interaction | RNF2 interactions | MED15 JCAD EP400 MAPKAPK2 ADAM9 BRD4 WASHC1 MARF1 AUTS2 ZFR FUBP3 YTHDF2 SP7 TBX5 | 1.10e-05 | 866 | 83 | 14 | int:RNF2 |
| Interaction | LSM14A interactions | 1.18e-05 | 260 | 83 | 8 | int:LSM14A | |
| Interaction | SMAP2 interactions | 1.30e-05 | 189 | 83 | 7 | int:SMAP2 | |
| Interaction | DPF2 interactions | 1.35e-05 | 349 | 83 | 9 | int:DPF2 | |
| Interaction | RUNX2 interactions | 1.35e-05 | 126 | 83 | 6 | int:RUNX2 | |
| Interaction | MED23 interactions | 1.39e-05 | 266 | 83 | 8 | int:MED23 | |
| Interaction | R3HDM2 interactions | 1.54e-05 | 129 | 83 | 6 | int:R3HDM2 | |
| Interaction | EWSR1 interactions | MED15 PRR12 SEC24D PRMT8 CDK12 BICRA BRD4 MAZ ZFR BCL9 CREBBP BAG6 EP300 TBX5 | 1.83e-05 | 906 | 83 | 14 | int:EWSR1 |
| Interaction | MAU2 interactions | 2.08e-05 | 136 | 83 | 6 | int:MAU2 | |
| Interaction | MED1 interactions | 2.27e-05 | 206 | 83 | 7 | int:MED1 | |
| Interaction | CNOT3 interactions | 2.34e-05 | 207 | 83 | 7 | int:CNOT3 | |
| Interaction | WNK1 interactions | 2.56e-05 | 141 | 83 | 6 | int:WNK1 | |
| Interaction | NFIB interactions | 2.66e-05 | 142 | 83 | 6 | int:NFIB | |
| Interaction | TLE1 interactions | 2.81e-05 | 213 | 83 | 7 | int:TLE1 | |
| Interaction | TNXB interactions | 2.96e-05 | 15 | 83 | 3 | int:TNXB | |
| Interaction | CPEB1 interactions | 3.11e-05 | 146 | 83 | 6 | int:CPEB1 | |
| Interaction | TSG101 interactions | 3.53e-05 | 303 | 83 | 8 | int:TSG101 | |
| Interaction | CDK8 interactions | 3.66e-05 | 222 | 83 | 7 | int:CDK8 | |
| Interaction | FOXI1 interactions | 3.90e-05 | 92 | 83 | 5 | int:FOXI1 | |
| Interaction | MED25 interactions | 4.10e-05 | 93 | 83 | 5 | int:MED25 | |
| Interaction | RERE interactions | 4.10e-05 | 93 | 83 | 5 | int:RERE | |
| Interaction | ZNF608 interactions | 4.10e-05 | 93 | 83 | 5 | int:ZNF608 | |
| Interaction | HDAC1 interactions | TNRC18 ZNF219 MRTFB KMT2B EP400 NFATC1 KLF5 BRD4 BANP RERE KMT2E CREBBP MNT EP300 SMAD5 | 4.14e-05 | 1108 | 83 | 15 | int:HDAC1 |
| Interaction | H3C14 interactions | 4.51e-05 | 156 | 83 | 6 | int:H3C14 | |
| Interaction | C2CD5 interactions | 4.55e-05 | 95 | 83 | 5 | int:C2CD5 | |
| Interaction | FOSB interactions | 4.92e-05 | 49 | 83 | 4 | int:FOSB | |
| Interaction | KLF4 interactions | 5.20e-05 | 160 | 83 | 6 | int:KLF4 | |
| Interaction | SMC5 interactions | LENG8 PCBP3 EP400 TJP1 CDK12 BICRA BRD4 MAZ YLPM1 MARF1 ZFR PABPC1 FUBP3 YTHDF2 | 5.39e-05 | 1000 | 83 | 14 | int:SMC5 |
| Interaction | CPSF6 interactions | 5.94e-05 | 526 | 83 | 10 | int:CPSF6 | |
| Interaction | ZYX interactions | 6.31e-05 | 329 | 83 | 8 | int:ZYX | |
| Interaction | TP53BP1 interactions | 6.63e-05 | 533 | 83 | 10 | int:TP53BP1 | |
| Interaction | FOXP3 interactions | 7.11e-05 | 432 | 83 | 9 | int:FOXP3 | |
| Interaction | GATA1 interactions | 7.52e-05 | 171 | 83 | 6 | int:GATA1 | |
| Interaction | USP7 interactions | SOX9 PRR12 TSC22D1 NEDD4L FAM186A BRD4 YLPM1 ZFR CGNL1 PAK6 KMT2E PABPC1 CREBBP BAG6 EP300 TBX5 | 7.81e-05 | 1313 | 83 | 16 | int:USP7 |
| Interaction | SMAD6 interactions | 8.35e-05 | 56 | 83 | 4 | int:SMAD6 | |
| Interaction | TLX1 interactions | 8.54e-05 | 175 | 83 | 6 | int:TLX1 | |
| Interaction | TEAD1 interactions | 8.81e-05 | 176 | 83 | 6 | int:TEAD1 | |
| Interaction | PRPF40A interactions | 9.07e-05 | 446 | 83 | 9 | int:PRPF40A | |
| Interaction | PAX8 interactions | 9.55e-05 | 111 | 83 | 5 | int:PAX8 | |
| Interaction | HMGXB4 interactions | 1.04e-04 | 113 | 83 | 5 | int:HMGXB4 | |
| Interaction | ARID3B interactions | 1.04e-04 | 113 | 83 | 5 | int:ARID3B | |
| Interaction | USP13 interactions | 1.08e-04 | 114 | 83 | 5 | int:USP13 | |
| Interaction | SMARCD2 interactions | 1.09e-04 | 183 | 83 | 6 | int:SMARCD2 | |
| Cytoband | 9p24.3 | 2.97e-04 | 14 | 84 | 2 | 9p24.3 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.80e-07 | 25 | 51 | 4 | 775 | |
| GeneFamily | Cyclins|Mediator complex | 1.09e-04 | 33 | 51 | 3 | 1061 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.19e-04 | 34 | 51 | 3 | 487 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 9.13e-04 | 16 | 51 | 2 | 14 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.03e-03 | 17 | 51 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.16e-03 | 18 | 51 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 2.09e-03 | 90 | 51 | 3 | 88 | |
| GeneFamily | Cyclin dependent kinases | 2.43e-03 | 26 | 51 | 2 | 496 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.43e-03 | 26 | 51 | 2 | 904 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.81e-03 | 53 | 51 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 2.22e-02 | 213 | 51 | 3 | 725 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 3.12e-06 | 197 | 83 | 7 | M8980 | |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN | 3.45e-06 | 200 | 83 | 7 | M7859 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.71e-05 | 467 | 83 | 9 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.27e-05 | 484 | 83 | 9 | MM999 | |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_2HR_UP | 2.43e-05 | 53 | 83 | 4 | M2585 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 4.12e-05 | 199 | 83 | 6 | M7885 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP | 4.24e-05 | 200 | 83 | 6 | M9748 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP | 4.24e-05 | 200 | 83 | 6 | M9742 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP | 4.24e-05 | 200 | 83 | 6 | M9591 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.24e-05 | 200 | 83 | 6 | M9188 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.72e-07 | 174 | 84 | 6 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | facs|World / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 182 | 84 | 6 | 08f775135b451be709f5fc8e1cbcf63425794a2e | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 184 | 84 | 6 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-06 | 187 | 84 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 189 | 84 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 190 | 84 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 195 | 84 | 6 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-06 | 197 | 84 | 6 | 0c8650bde08e1317baee4793201645d86f16e15d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-06 | 199 | 84 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.41e-06 | 138 | 84 | 5 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 167 | 84 | 5 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 174 | 84 | 5 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Basal-basal-3|World / Class top | 2.02e-05 | 175 | 84 | 5 | a0d7ced5204a9efbbb91ac99410a088f8ed2df0f | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 2.20e-05 | 178 | 84 | 5 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 186 | 84 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-05 | 188 | 84 | 5 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.00e-05 | 190 | 84 | 5 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.00e-05 | 190 | 84 | 5 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 191 | 84 | 5 | 4180521a8c5e0ad629cacdd22dc6a94e94b28816 | |
| ToppCell | wk_08-11-Epithelial-PNS-KCNIP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.16e-05 | 192 | 84 | 5 | 53642c88891f4e4e14b1740c5ced759b7d8b3572 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-05 | 192 | 84 | 5 | f40a7f8771aa9891a6fd59b9c8eac2fd792efa9b | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 3.32e-05 | 194 | 84 | 5 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.32e-05 | 194 | 84 | 5 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 3.40e-05 | 195 | 84 | 5 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | droplet-Mammary_Gland-nan-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 195 | 84 | 5 | c771ac1db8bd5f3a80bd3484094a58c28983f97b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 195 | 84 | 5 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 195 | 84 | 5 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.40e-05 | 195 | 84 | 5 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 196 | 84 | 5 | 81f9754567bbfa67edd304b9ef7b03e7bd9a3b52 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 197 | 84 | 5 | 01e9505d947e5a5f005d1eab96301f84fc194809 | |
| ToppCell | Basal-basal-9|World / Class top | 3.57e-05 | 197 | 84 | 5 | 66db9eeb66b378471e4bccc2e6de51053d7cfa5c | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 3.65e-05 | 198 | 84 | 5 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-05 | 198 | 84 | 5 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 3.65e-05 | 198 | 84 | 5 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | Basal-basal-8|World / Class top | 3.65e-05 | 198 | 84 | 5 | 1ea1515e7320068762387e19f6b47c0cf185549a | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.65e-05 | 198 | 84 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 550590b1e9c1930cbbe9cf7a141c7aeb07413096 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related-Oligodendrocyte/OPC|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 80cec67b7557465320a847ba959a8a13f7c51566 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-OPC_related|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 8dafb90b418f91a0fb56c97db06233d3eca358dc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-04 | 148 | 84 | 4 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 153 | 84 | 4 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 159 | 84 | 4 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | 343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 160 | 84 | 4 | 133ecae0a894d9a0d49d58859623359096b6f030 | |
| ToppCell | 343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 160 | 84 | 4 | a2f09b5955602819c8978f4372130c8ef915cd07 | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 2.44e-04 | 161 | 84 | 4 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 2.44e-04 | 161 | 84 | 4 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | Basal-basal-4|World / Class top | 2.74e-04 | 166 | 84 | 4 | 2721772eb2a9f45c5e9aaf4d73d198fea11a3586 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-04 | 166 | 84 | 4 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 166 | 84 | 4 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 2.87e-04 | 168 | 84 | 4 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.00e-04 | 170 | 84 | 4 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 3.00e-04 | 170 | 84 | 4 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-04 | 171 | 84 | 4 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 171 | 84 | 4 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 3.07e-04 | 171 | 84 | 4 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 172 | 84 | 4 | bd73fd3520064d430a153cfdd5c2858b6c184c59 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 172 | 84 | 4 | 47ee78ed3ba6516dad8f12dbf70bca5ed1c60aff | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.14e-04 | 172 | 84 | 4 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-04 | 174 | 84 | 4 | 583955b4db442ba0583e2312af242f050547f9d6 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 3.28e-04 | 174 | 84 | 4 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 3.35e-04 | 175 | 84 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-04 | 175 | 84 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 3.35e-04 | 175 | 84 | 4 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 3.35e-04 | 175 | 84 | 4 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.42e-04 | 176 | 84 | 4 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 3.50e-04 | 177 | 84 | 4 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-04 | 177 | 84 | 4 | 8c6d8a1c469346e66f9095d86b4615f8fc611362 | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 177 | 84 | 4 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.50e-04 | 177 | 84 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 3.50e-04 | 177 | 84 | 4 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | Control-Myeloid-pDC|World / Disease state, Lineage and Cell class | 3.57e-04 | 178 | 84 | 4 | 20ef63d925e67ddd5955832312ca8574a6f838a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-04 | 179 | 84 | 4 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 3.65e-04 | 179 | 84 | 4 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.65e-04 | 179 | 84 | 4 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-04 | 180 | 84 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-04 | 180 | 84 | 4 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.72e-04 | 180 | 84 | 4 | 6f8fa9fa91cd25b92584972bb34d90c483222f52 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.80e-04 | 181 | 84 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 181 | 84 | 4 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 3.80e-04 | 181 | 84 | 4 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 3.80e-04 | 181 | 84 | 4 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | facs-Thymus-Epithelium-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | bce56e12ab93693c9c04fa6aad8f2e1dff0c4d45 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 3.80e-04 | 181 | 84 | 4 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.80e-04 | 181 | 84 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | COVID-19_Severe-PLT_1|COVID-19_Severe / Disease Group and Platelet Clusters | 3.80e-04 | 181 | 84 | 4 | 20f7603ceb89b965570e39ae3e88a6d26ebf5b67 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.88e-04 | 182 | 84 | 4 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 3.88e-04 | 182 | 84 | 4 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-04 | 182 | 84 | 4 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 182 | 84 | 4 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.88e-04 | 182 | 84 | 4 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.88e-04 | 182 | 84 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-04 | 182 | 84 | 4 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.88e-04 | 182 | 84 | 4 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 5.94e-07 | 196 | 83 | 8 | 2515_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 7.03e-06 | 194 | 83 | 7 | 2469_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A | 7.52e-06 | 196 | 83 | 7 | 7123_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.77e-06 | 197 | 83 | 7 | 3415_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; HL60; HT_HG-U133A | 8.03e-06 | 198 | 83 | 7 | 2521_UP | |
| Drug | PCI 5002 | LENG8 TNRC18 NEDD4L NFATC1 MED9 FOSB BANP SLC35A2 NR4A3 SIAH2 PLK3 MNT | 1.39e-05 | 735 | 83 | 12 | ctd:C568608 |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A | 4.24e-05 | 174 | 83 | 6 | 2452_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.96e-05 | 179 | 83 | 6 | 3895_UP | |
| Drug | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 5.88e-05 | 113 | 83 | 5 | ctd:C434003 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 6.14e-05 | 186 | 83 | 6 | 2684_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 6.33e-05 | 187 | 83 | 6 | 3386_UP | |
| Drug | hydroxytamoxifen | 6.94e-05 | 117 | 83 | 5 | ctd:C475919 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 1670_DN | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 2504_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.75e-05 | 194 | 83 | 6 | 3861_DN | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; HL60; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 3120_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 3185_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 2653_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 7.98e-05 | 195 | 83 | 6 | 3135_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2473_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 2331_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.21e-05 | 196 | 83 | 6 | 5533_UP | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; HL60; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2728_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 5456_UP | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.44e-05 | 197 | 83 | 6 | 1015_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 1697_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 8.44e-05 | 197 | 83 | 6 | 2766_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2725_UP | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 2489_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 6176_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 1544_UP | |
| Drug | arachidonic acid sodium salt; Up 200; 10uM; MCF7; HG-U133A | 8.68e-05 | 198 | 83 | 6 | 443_UP | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 8.68e-05 | 198 | 83 | 6 | 3898_UP | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 1509_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 6219_DN | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; PC3; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 7250_UP | |
| Drug | cobalt(II) chloride hexahydrate; Up 200; 100uM; MCF7; HG-U133A | 8.92e-05 | 199 | 83 | 6 | 454_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 3338_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 8.92e-05 | 199 | 83 | 6 | 2266_UP | |
| Drug | Phenylephrine | 9.28e-05 | 505 | 83 | 9 | ctd:D010656 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.30e-04 | 5 | 83 | 2 | ctd:C575894 | |
| Drug | Asbestos, Crocidolite | SOX9 TSC22D1 CUX2 MRTFB KMT2B NEDD4L TJP1 MAPKAPK2 SGK1 FOSB DAB2 NR4A3 SMAD5 TBX5 | 1.47e-04 | 1241 | 83 | 14 | ctd:D017638 |
| Disease | Intellectual Disability | 4.66e-07 | 447 | 82 | 10 | C3714756 | |
| Disease | Carcinoma, Transitional Cell | 5.19e-06 | 41 | 82 | 4 | C0007138 | |
| Disease | Menke-Hennekam syndrome | 7.63e-06 | 2 | 82 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.63e-06 | 2 | 82 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 7.63e-06 | 2 | 82 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.63e-06 | 2 | 82 | 2 | C4551859 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.63e-06 | 2 | 82 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.63e-06 | 2 | 82 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.63e-06 | 2 | 82 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 7.63e-06 | 2 | 82 | 2 | C0035934 | |
| Disease | Small cell carcinoma of lung | 1.58e-05 | 54 | 82 | 4 | C0149925 | |
| Disease | Bladder Neoplasm | 4.55e-05 | 140 | 82 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.71e-05 | 141 | 82 | 5 | C0005684 | |
| Disease | alcohol drinking | 7.83e-05 | 81 | 82 | 4 | EFO_0004329 | |
| Disease | Adenoid Cystic Carcinoma | 1.77e-04 | 100 | 82 | 4 | C0010606 | |
| Disease | aortic valve stenosis (is_marker_for) | 4.13e-04 | 11 | 82 | 2 | DOID:1712 (is_marker_for) | |
| Disease | 46,XY partial gonadal dysgenesis | 4.13e-04 | 11 | 82 | 2 | C4510744 | |
| Disease | neutrophil count | JCAD CUX2 CCDC200 SPRR5 FAM186A KLF5 RERE BCL9 KMT2E CREBBP CABLES1 SP7 | 4.23e-04 | 1382 | 82 | 12 | EFO_0004833 |
| Disease | Diffuse Large B-Cell Lymphoma | 4.89e-04 | 55 | 82 | 3 | C0079744 | |
| Disease | Abnormality of refraction | 5.68e-04 | 673 | 82 | 8 | HP_0000539 | |
| Disease | body weights and measures, body height | 7.82e-04 | 15 | 82 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | prostate cancer (is_marker_for) | 9.54e-04 | 156 | 82 | 4 | DOID:10283 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | 9.80e-04 | 914 | 82 | 9 | EFO_0004532 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 1.01e-03 | 17 | 82 | 2 | C1839839 | |
| Disease | obsolete_red blood cell distribution width | KMT2B EP400 CDK12 BRD4 CLPTM1 BANP YLPM1 SIAH2 CHSY3 EP300 SP7 | 1.23e-03 | 1347 | 82 | 11 | EFO_0005192 |
| Disease | Leukemia, Myelocytic, Acute | 1.40e-03 | 173 | 82 | 4 | C0023467 | |
| Disease | Cleft Palate | 1.51e-03 | 81 | 82 | 3 | C0008925 | |
| Disease | Squamous cell carcinoma of esophagus | 2.38e-03 | 95 | 82 | 3 | C0279626 | |
| Disease | Sezary Syndrome | 2.56e-03 | 27 | 82 | 2 | C0036920 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.64e-03 | 206 | 82 | 4 | C0152013 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 2.75e-03 | 28 | 82 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | Pancreatic Neoplasm | 2.76e-03 | 100 | 82 | 3 | C0030297 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STPPPASELPQPQPQ | 351 | Q8N9N5 | |
| PQTPQPTSQPQPTPP | 1866 | Q09472 | |
| QASTPGQPPPQPQAP | 1561 | Q96L91 | |
| QPPPPLPQPQAAGSQ | 2556 | Q96L91 | |
| PPPPQAQSAPPQPTA | 2831 | Q96L91 | |
| PAFPQPPALVAQQPP | 341 | Q5SZQ8 | |
| PQQPPLPPSQPAFSQ | 561 | Q9NYV4 | |
| PQQAAAPPQAPPPQQ | 386 | Q9BWU1 | |
| QPQHSQPPPQPPAVT | 196 | P46379 | |
| PQPKPQAPPSQPLPQ | 416 | Q2M2I8 | |
| QPQPPPAPAPQPVQS | 256 | O60885 | |
| RNNPVNPPLATPQPP | 461 | P51816 | |
| NPPLATPQPPPAVQA | 466 | P51816 | |
| QTPQPPAQPQPSPVS | 1901 | Q92793 | |
| VNSPPSQPPQPVVPA | 26 | Q9NR22 | |
| PPPNQTPAPDQPFAL | 86 | P53701 | |
| EQSYPSPQQLPPPPG | 436 | O14529 | |
| LNPASQPQAPPKPIP | 71 | Q6NXP0 | |
| PPISQQVLQPPPSPQ | 611 | Q9UBL0 | |
| PPSPQGFVQQPPPAQ | 621 | Q9UBL0 | |
| TPQPAPQLPLNAAPP | 316 | Q3YEC7 | |
| PHPSQAFGPQPPQQP | 961 | Q9H3S7 | |
| AVPNPVINPYQPAPP | 391 | P11940 | |
| NQPSPFAASTPPPVP | 556 | P98082 | |
| PPPQSKPNSSFRPPQ | 281 | Q9NQU5 | |
| ANTQPTPLPQPPPPT | 1531 | Q8NEZ4 | |
| QNNLSNPPTPPASLP | 3891 | Q8NEZ4 | |
| TPNSPIAQPAPPQPL | 1046 | Q86UL8 | |
| PPPPPQQFPQFHVKS | 36 | P49137 | |
| PPPPLNTSPMNPPNQ | 301 | O95835 | |
| FFQPPPPRPPNPQNV | 446 | Q0VAK6 | |
| PPRPPNPQNVPFSQR | 451 | Q0VAK6 | |
| VPPPSYRSPPQNIPN | 341 | Q9P266 | |
| APPQQLPSAQPPQPS | 156 | Q96PV6 | |
| FSQPPAPPHQNTFPP | 441 | Q96I24 | |
| QNGPNTPNKPSSPPP | 836 | Q9ULH7 | |
| TPNKPSSPPPPQQFV | 841 | Q9ULH7 | |
| QPPPALLPQQVSAPP | 816 | O95644 | |
| PPQGPPEAQLQPAPQ | 341 | Q8WXX7 | |
| PPPVPPTKQQYLCQP | 606 | Q96RN5 | |
| QQSLNSTAPPPPPPP | 1536 | Q8IZD2 | |
| SPFQAAPAPPPTPQA | 61 | P56270 | |
| GVQPQLAPQQPPPPT | 181 | Q99583 | |
| QALPPPQPQLQPPPS | 751 | Q9UMN6 | |
| PQPQQSPAPRPQSPA | 41 | Q9NWA0 | |
| QTPFPPLGQTNPAFP | 251 | P57721 | |
| PPPLPFQTSQDAPPN | 261 | P53539 | |
| PSQPPPQPSTLPQAQ | 86 | A0A1B0GVQ3 | |
| QPQPAAAAPAQPPPE | 36 | Q8TDN4 | |
| LSFHQPPQQPPPPQE | 81 | Q8NE35 | |
| PAPQPAQPAQPPQAQ | 171 | Q8NE35 | |
| PQPQPQQPFLPPAAC | 16 | P50553 | |
| ENGPPFPPPVINNLP | 71 | Q0VF96 | |
| APQPPPASQPSQPQP | 106 | Q9NQL9 | |
| PKPLPQQPPAPANQD | 231 | O00512 | |
| FPPVQSPPQQVPFPH | 1141 | O00512 | |
| KQPQQFPSRPPPPQP | 781 | Q13443 | |
| QPAPPTSQPPRAQPF | 36 | Q9BUT9 | |
| PNIPPPNTQPAPLAV | 291 | Q9Y4F3 | |
| PPPAPSQQQPPQQHS | 196 | Q53TQ3 | |
| AQFPAPQAPPSPGQL | 1811 | A6NE01 | |
| QPPQAPTPQAAAPPQ | 646 | Q9NZM4 | |
| PLQQEPSQPSPPSPP | 381 | Q92570 | |
| SQDLLPPPNPYPLPQ | 301 | Q99593 | |
| QPPPSTNQHPQPAPQ | 196 | P78424 | |
| QQPPPASQQPPAPTS | 226 | P78424 | |
| ANPSPPPSPSQQINL | 71 | O00141 | |
| SKQPPPQPQHTPSPA | 16 | O43255 | |
| PAQPPGLTQSQNLPP | 1001 | Q9P2R6 | |
| GPQPPPPQSLNLLSQ | 76 | Q15714 | |
| QAPPAPQAPPQPQAA | 351 | P48436 | |
| QPQAAPPQQPAAPPQ | 361 | P48436 | |
| PPQQPAAPPQQPQAH | 366 | P48436 | |
| QKSPPPPPPTAQSTQ | 761 | Q9ULL5 | |
| PPNAQYQPPPLPGQT | 201 | O94855 | |
| HQQPPGQPPPPQLSS | 361 | P78381 | |
| NNTPFPLSPNSPYPP | 181 | Q99717 | |
| PAETQPQNPPAQPAP | 36 | O96005 | |
| FSSQQPPNAGQPPPP | 206 | Q70JA7 | |
| TPAPQPQAPPPQPTQ | 2721 | O15417 | |
| PPAEQNPAPLAQPEP | 446 | Q9H4B4 | |
| VAQPQPQPPPQPSLS | 626 | Q6ZNA4 | |
| PPPQTQPPPQVDYVI | 671 | Q6ZNA4 | |
| PAQPPLNPQLPTYPS | 186 | Q8TDD2 | |
| PPPQQYCPPPQQTKQ | 66 | A0A1B0GTR4 | |
| VSDSIPPLPPPQQPQ | 441 | Q6VEQ5 | |
| VSDSIPPLPPPQQPQ | 441 | A8K0Z3 | |
| QVLEQVQSSPPPPPP | 301 | Q8IYU4 | |
| VQSSPPPPPPSQEQQ | 306 | Q8IYU4 | |
| QPYLPPAQPSPSQSP | 181 | P49750 | |
| PQFSSLQPPCFPPVQ | 216 | Q6P444 | |
| LQPPCFPPVQPGSNN | 221 | Q6P444 | |
| PPPPPLPSQYAQPSQ | 1426 | Q07157 | |
| TQRQQEAPPPPPPAT | 121 | Q96KR1 | |
| EAPPPPPPATTQNYQ | 126 | Q96KR1 | |
| ATSAAPPPQPQPQPP | 221 | Q9P2Y4 | |
| SVGQQTQPLPPPPPQ | 321 | Q9Y5A9 | |
| QPAPAQAPQPAQPPA | 61 | Q13887 | |
| ASKQQPAPPPQPPES | 16 | Q14003 | |
| NPQSPQPSPYNSPKP | 476 | Q96PU5 |